Charles J Casamento - Net Worth and Insider Trading

Charles J Casamento Net Worth

The estimated net worth of Charles J Casamento is at least $262,034 dollars as of 2024-05-19. Charles J Casamento is the Director of Eton Pharmaceuticals Inc and owns about 71,920 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $260,350. Charles J Casamento is the Director of Entero Therapeutics Inc and owns about 305 shares of Entero Therapeutics Inc (ENTO) stock worth over $909. Charles J Casamento is also the Director of VIVUS Inc and owns about 6,600 shares of VIVUS Inc (VVUSQ) stock worth over $775. Besides these, Charles J Casamento also holds Relmada Therapeutics Inc (RLMD) . Details can be seen in Charles J Casamento's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles J Casamento has not made any transactions after 2023-09-15 and currently still holds the listed stock(s).

Transaction Summary of Charles J Casamento

To

Charles J Casamento Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles J Casamento owns 9 companies in total, including Relmada Therapeutics Inc (RLMD) , Entero Therapeutics Inc (ENTO) , and Eton Pharmaceuticals Inc (ETON) among others .

Click here to see the complete history of Charles J Casamento’s form 4 insider trades.

Insider Ownership Summary of Charles J Casamento

Ticker Comapny Transaction Date Type of Owner
RLMD Relmada Therapeutics Inc 2022-04-01 director
ENTO Entero Therapeutics Inc 2023-09-15 director
ETON Eton Pharmaceuticals Inc 2019-08-09 director
2010-06-21 director
2013-01-25 director
2003-12-09 director
2006-10-05 director & CEO & President
2023-05-01 director
2023-10-02 director

Charles J Casamento Latest Holdings Summary

Charles J Casamento currently owns a total of 4 stocks. Among these stocks, Charles J Casamento owns 71,920 shares of Eton Pharmaceuticals Inc (ETON) as of August 9, 2019, with a value of $260,350 and a weighting of 99.36%. Charles J Casamento owns 305 shares of Entero Therapeutics Inc (ENTO) as of September 15, 2023, with a value of $909 and a weighting of 0.35%. Charles J Casamento also owns 6,600 shares of VIVUS Inc (VVUSQ) as of August 20, 2012, with a value of $775 and a weighting of 0.3%. The other 1 stocks Relmada Therapeutics Inc (RLMD) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Charles J Casamento

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ETON Eton Pharmaceuticals Inc 2019-08-09 71,920 3.62 260,350
ENTO Entero Therapeutics Inc 2023-09-15 305 2.98 909
VVUSQ VIVUS Inc 2012-08-20 6,600 0.12 775
RLMD Relmada Therapeutics Inc 2022-04-01 0 3.34 0

Holding Weightings of Charles J Casamento


Charles J Casamento Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles J Casamento has made a total of 1 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 3,500 shares on August 9, 2019, which cost Charles J Casamento around $21,385.

According to the SEC Form 4 filings, Charles J Casamento has made a total of 2 transactions in Entero Therapeutics Inc (ENTO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Entero Therapeutics Inc is the sale of 1 shares on September 15, 2023, which brought Charles J Casamento around $4.

According to the SEC Form 4 filings, Charles J Casamento has made a total of 0 transactions in VIVUS Inc (VVUSQ) over the past 5 years. The most-recent trade in VIVUS Inc is the sale of 800 shares on August 20, 2012, which brought Charles J Casamento around $165,040.

More details on Charles J Casamento's insider transactions can be found in the Insider Trading History of Charles J Casamento table.

Insider Trading History of Charles J Casamento

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles J Casamento Trading Performance

GuruFocus tracks the stock performance after each of Charles J Casamento's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles J Casamento is 9.72%. GuruFocus also compares Charles J Casamento's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles J Casamento within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Charles J Casamento's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Charles J Casamento

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.25
Relative Return to S&P 500(%) 6.58

Charles J Casamento Ownership Network

Ownership Network List of Charles J Casamento

No Data

Ownership Network Relation of Charles J Casamento


Charles J Casamento Owned Company Details

What does Relmada Therapeutics Inc do?

Who are the key executives at Relmada Therapeutics Inc?

Charles J Casamento is the director of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include director & Chief Executive Officer Sergio Traversa , Chief Financial Officer Chuck Ence , and Chief Medical Officer Cedric O'gorman .

Relmada Therapeutics Inc (RLMD) Insider Trades Summary

Over the past 18 months, Charles J Casamento made no insider transaction in Relmada Therapeutics Inc (RLMD). Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 155,250 shares made by Sergio Traversa , a net purchase of 38,970 shares made by Chuck Ence , and a net purchase of 32,675 shares made by Maged Shenouda .

In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 236,895 shares were bought by its insiders, resulting in a net purchase of 236,895 shares.

Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Relmada Therapeutics Inc Insider Transactions

No Available Data

Charles J Casamento Mailing Address

Above is the net worth, insider trading, and ownership report for Charles J Casamento. You might contact Charles J Casamento via mailing address: 99 Belbrook Way, Atherton Ca 94027.

Discussions on Charles J Casamento

No discussions yet.